About Sanford Madigan
Form D filings for Valora Therapeutics in 2024 list Sanford Madigan as director.
Sanford Madigan first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Sanford Madigan in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Sanford Madigan works with at each company, as listed on that company's latest Form D.
Valora Therapeutics, Inc. · Form D, Jul 24, 2024
MG
Miguel Garcia-Guzman
Chief Executive Officer and director
SH
Stefan Heller
Director